SATB2-LEMD2 interaction links nuclear shape plasticity to regulation of cognition-related genes.
Patrick FeurleAndreas AbentungIsabella CeraNico WahlCornelia AblingerMichael BucherEduard StefanSimon SprengerDavid TeisAndre FischerAodán LaighneachLaura WhittonDerek W MorrisGalina ApostolovaGeorg DechantPublished in: The EMBO journal (2020)
SATB2 is a schizophrenia risk gene and is genetically associated with human intelligence. How it affects cognition at molecular level is currently unknown. Here, we show that interactions between SATB2, a chromosomal scaffolding protein, and the inner nuclear membrane protein LEMD2 orchestrate the response of pyramidal neurons to neuronal activation. Exposure to novel environment in vivo causes changes in nuclear shape of CA1 hippocampal neurons via a SATB2-dependent mechanism. The activity-driven plasticity of the nuclear envelope requires not only SATB2, but also its protein interactor LEMD2 and the ESCRT-III/VPS4 membrane-remodeling complex. Furthermore, LEMD2 depletion in cortical neurons, similar to SATB2 ablation, affects neuronal activity-dependent regulation of multiple rapid and delayed primary response genes. In human genetic data, LEMD2-regulated genes are enriched for de novo mutations reported in intellectual disability and schizophrenia and are, like SATB2-regulated genes, enriched for common variants associated with schizophrenia and cognitive function. Hence, interactions between SATB2 and the inner nuclear membrane protein LEMD2 influence gene expression programs in pyramidal neurons that are linked to cognitive ability and psychiatric disorder etiology.
Keyphrases
- genome wide
- intellectual disability
- gene expression
- bipolar disorder
- copy number
- spinal cord
- endothelial cells
- genome wide identification
- dna methylation
- autism spectrum disorder
- transcription factor
- mild cognitive impairment
- cerebral ischemia
- bioinformatics analysis
- spinal cord injury
- white matter
- amino acid
- blood brain barrier
- small molecule
- single molecule